Showing results (71-80 of 224) with videos related to
Sort By:
Pageof 23
Biology of the Neonate|January 1, 1991
Symptomatic patent ductus arteriosus following prophylactic indomethacin. A clinical and biochemical appraisalR B Cotton, J L Haywood, G A FitzGeraldClinical Science (London, England : 1979)|April 1, 1982
Circadian variation in adrenergic responses in asthmatic subjectsP J Barnes, G A Fitzgerald, C T DolleryThe Journal of Nutrition|March 21, 1998
Eicosanoids and isoeicosanoids: indices of cellular function and oxidant stressM P Reilly, J A Lawson, G A FitzGeraldJournal of Clinical Pathology|November 1, 1988
Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemiaI A Reilly, H R Knapp, G A FitzgeraldThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alphaB T Kinsella, D J O'Mahony, G A FitzgeraldThe Journal of Biological Chemistry|August 29, 1998
Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase cE M Smyth, W H Li, G A FitzGeraldTrends in Endocrinology and Metabolism: TEM|July 11, 2001
The isoprostanes in biology and medicineD Praticò, J A Lawson, J Rokach, et al.The Journal of Biological Chemistry|April 25, 1990
The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systemsK Takahara, R Murray, G A FitzGerald, et al.Molecular Pharmacology|November 1, 1993
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sitesC D Funk, L Furci, N Moran, et al.Analytical Biochemistry|May 15, 1986
Long-lived enzymatic metabolites of thromboxane B2 in the human circulationJ A Lawson, C Patrono, G Ciabattoni, et al.Pageof 23